| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |